J. Goldman & CO LP Global Blood Therapeutics, Inc. Transaction History

J. Goldman & CO LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $1.95 Million - $3.26 Million	-87,312 Reduced 76.53%	26,780 $856,000
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $2.93 Million - $4.06 Million	114,092 New	114,092 $3.95 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $1.78 Million - $2.14 Million	-33,789 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $2,199 - $2,941	-55 Reduced 0.16%	33,789 $1.79 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $1.07 Million - $1.58 Million	33,844 New	33,844 $1.39 Million
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $677,250 - $877,625	-17,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $693,000 - $1.15 Million	17,500 New	17,500 $845,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.